ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN\u00ae for Use in Patients with Diabetic Macular Ede

  • Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the aflibercept arm